Rathbones Group PLC Maxcyte, Inc. Transaction History
Rathbones Group PLC
- $19 Billion
- Q3 2024
A detailed history of Rathbones Group PLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 253,107 shares of MXCT stock, worth $870,688. This represents 0.01% of its overall portfolio holdings.
Number of Shares
253,107
Previous 262,741
3.67%
Holding current value
$870,688
Previous $1.03 Million
4.37%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.5MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$28.2 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$19.9 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$17.3 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$16.6 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $350M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...